within Pharmacolibrary.Drugs.ATC.N;

model N02AJ16
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.7,
    Cl             = 0.006666666666666667,
    adminDuration  = 600,
    adminMass      = 0.1,
    adminCount     = 1,
    Vd             = 0.0027,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.008333333333333333,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>This combination drug contains tramadol, an opioid analgesic, and celecoxib, a selective COX-2 inhibitor NSAID, used for the management of moderate to severe pain where opioid treatment is appropriate and NSAIDs are desired. The fixed combination (ATC code N02AJ16) is approved in some regions for short-term management of acute pain.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic model describing the fixed-dose combination of tramadol and celecoxib could be found. Typical PK parameters were estimated based on published mono-therapy pharmacokinetic models for orally administered tramadol and celecoxib in healthy adults.</p><h4>References</h4><ol><li><p>Langford, R, et al., &amp; Plata-Salamán, C (2022). Efficacy and safety of co-crystal of tramadol-celecoxib (CTC) in acute moderate-to-severe pain after abdominal hysterectomy: A randomized, double-blind, phase 3 trial (STARDOM2). <i>European journal of pain (London, England)</i> 26(10) 2083–2096. DOI:<a href=&quot;https://doi.org/10.1002/ejp.2021&quot;>10.1002/ejp.2021</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/35974668/&quot;>https://pubmed.ncbi.nlm.nih.gov/35974668</a></p></li><li><p>Dooner, H, et al., &amp; Smith, K (2019). Pharmacokinetics of Tramadol and Celecoxib in Japanese and Caucasian Subjects Following Administration of Co-Crystal of Tramadol-Celecoxib (CTC): A Randomised, Open-Label Study. <i>European journal of drug metabolism and pharmacokinetics</i> 44(1) 63–75. DOI:<a href=&quot;https://doi.org/10.1007/s13318-018-0491-9&quot;>10.1007/s13318-018-0491-9</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29956215/&quot;>https://pubmed.ncbi.nlm.nih.gov/29956215</a></p></li><li><p>Encina, G, et al., &amp; Videla, S (2018). The Effect of Food on Tramadol and Celecoxib Bioavailability Following Oral Administration of Co-Crystal of Tramadol-Celecoxib (CTC): A Randomised, Open-Label, Single-Dose, Crossover Study in Healthy Volunteers. <i>Clinical drug investigation</i> 38(9) 819–827. DOI:<a href=&quot;https://doi.org/10.1007/s40261-018-0672-y&quot;>10.1007/s40261-018-0672-y</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/30008052/&quot;>https://pubmed.ncbi.nlm.nih.gov/30008052</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end N02AJ16;
